This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Glaxo Admits China Execs May Have Broken the Law: Ahead of the Ticker

NEW YORK ( TheStreet) -- GlaxoSmithKline (GSK - Get Report) revealed that some of its senior executives in China may have broken the law.

The acknowledgment comes after China accused the British drugmaker of bribing hospital workers, doctors and government officials.

GSK executive Abbas Hussain, who went to China to investigate the accusation, said in a statement, "Certain senior executives of GSK China who know our systems well, appear to have acted outside of our processes and controls which breaches Chinese law."

Hussain added that the company has a zero tolerance policy regarding this type of behavior.

According to allegations, as much as 3 billion yuan ($490 million) was channeled through travel agencies and consulting firms to hide the bribery. Four GSK China employees are said to have been detained while the investigation proceeds.






UBS (UBS) reached an "agreement in principle" with the U.S. government to settle its lawsuit over its sale of mortgage-backed securities.

UBS said it reached the agreement with the U.S. Federal Housing Finance Agency over claims related to residential mortgage-backed securities it sold from 2004 to 2007. It said it will book 865 million francs in charges and writedowns related to the settlement as a result.

The FHFA sued 18 banks in 2011 in attempt to recoup losses on $196 billion in mortgage-backed securities sold to Fannie Mae and Freddie Mac. The agency accused UBS of doling out misleading statements and failing to conduct due diligence in selling $4.5 billion worth of these securities.

UBS reported net income of about 690 million Swiss francs ($734 million) for the second quarter, compared to 425 million francs in the same period last year. Some analysts expected the company to report net income of about 560 million francs, according to Thomson Reuters.






Toymaker Hasbro (HAS - Get Report) reported disappointing second-quarter earnings on weak demand for toys and merchandise for boys.

Hasbro said it earned $36.5 million, or 28 cents a share, for the quarter, down for $43.4 million, or 33 cents a share, a year ago. Analysts had expected earnings of 34 cents.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
GSK $44.37 -0.94%
HAS $72.13 -0.44%
UBS $21.58 -1.46%
AAPL $130.28 -1.14%
FB $79.19 -1.19%

Markets

DOW 18,010.68 -115.44 -0.64%
S&P 500 2,107.39 -13.40 -0.63%
NASDAQ 5,070.0260 -27.95 -0.55%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs